U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1991
122
Substance Class Mixture
Created
by admin
on Mon Mar 31 18:20:56 GMT 2025
Edited
by admin
on Mon Mar 31 18:20:56 GMT 2025
Record UNII
S866O45PIG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Beractant
MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN  
Official Name English
SURVANTA
Preferred Name English
PULMONARY SURFACTANT WHICH IS A NATURAL BOVINE LUNG EXTRACT CONTAINING PHOSPHOLIPIDS, NEUTRAL LIPIDS, FATTY ACIDS, AND SURFACTANT-ASSOCIATED PROTEINS (SP) TO WHICH COLFOSCERIL PALMITATE (DIPALMITOYLPHOSPHATIDYLCHOLINE), PALMITIC ACID, AND TRIPALMITIN ARE
Common Name English
BERACTANT [USAN]
Common Name English
BERACTANT [VANDF]
Common Name English
Beractant [WHO-DD]
Common Name English
COMPOSITION PROVIDES 25 MG/ML OF PHOSPHOLIPIDS (INCLUDING 11.0-15.5 MG/ML OF DISATURATED PHOSPHATIDYLCHOLINE), 0.5-1.75 MG/ML OF TRIGLYCERIDES, 1.4-3.5 MG/ML OF FREE FATTY ACIDS, AND LESS THAN 1 MG/ML OF SP-C
Common Name English
BERACTANT [ORANGE BOOK]
Common Name English
BERACTANT [MART.]
Common Name English
PULMONARY SURFACTANT WHICH IS A NATURAL BOVINE LUNG EXTRACT CONTAINING PHOSPHOLIPIDS, NEUTRAL LIPIDS, FATTY ACIDS, AND SURFACTANT-ASSOCIATED PROTEINS (SP) TO WHICH COLFOSCERIL PALMITATE (DIPALMITOYLPHOSPHATIDYLCHOLINE), PALMITIC ACID, AND TRIPALMITIN ARE
Common Name English
BERACTANT [MI]
Common Name English
SURFACTANT TA
Common Name English
A-60386X
Code English
Classification Tree Code System Code
NCI_THESAURUS C78273
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
FDA ORPHAN DRUG 390113
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
FDA ORPHAN DRUG 76793
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
NDF-RT N0000008294
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
NDF-RT N0000175778
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
NDF-RT N0000000079
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
FDA ORPHAN DRUG 10885
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
Code System Code Type Description
MERCK INDEX
m2423
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY Merck Index
USAN
Y-80
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
DAILYMED
S866O45PIG
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
DRUG BANK
DB06761
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
CAS
108778-82-1
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID70883180
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201624
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
NCI_THESAURUS
C81354
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
RXCUI
46967
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY RxNorm
SMS_ID
100000115273
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
WIKIPEDIA
BERACTANT
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
FDA UNII
S866O45PIG
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
EVMPD
SUB13043MIG
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
MESH
C072197
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
DRUG CENTRAL
5108
Created by admin on Mon Mar 31 18:20:56 GMT 2025 , Edited by admin on Mon Mar 31 18:20:56 GMT 2025
PRIMARY
All of the following components must be present:
Structure of COLFOSCERIL PALMITATE
Structure of TRIPALMITIN
Structure of PALMITIC ACID
BOVINE LUNG LIPIDS SP-C RICH
Related Record Type Details
Beractant
ACTIVE MOIETY
Definition References
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966